Healthcare - Biotechnology - NASDAQ - US
$ 0.46
2.68 %
$ 43.4 M
Market Cap
-1.35
P/E
BALANCE SHEET
14.2 M
ASSETS
18 M
LIABILITIES
-3.81 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Unicycive Therapeutics, Inc.
| Current Assets | 13.4 M |
| Cash & Short-Term Investments | 9.7 M |
| Receivables | 0 |
| Other Current Assets | 3.7 M |
| Non-Current Assets | 792 K |
| Long-Term Investments | 0 |
| PP&E | 792 K |
| Other Non-Current Assets | 0 |
| Current Liabilities | 17.5 M |
| Accounts Payable | 821 K |
| Short-Term Debt | 345 K |
| Other Current Liabilities | 16.4 M |
| Non-Current Liabilities | 466 K |
| Long-Term Debt | 466 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 9.7 | 0.5 | 16.6 | 0 | 15 K | 25 K |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.7 | 2.2 | 1.8 | 0.2 | 4 K | 4 K |
| Total Current Assets | 13.4 | 2.6 | 18.4 | 0.2 | 19 K | 29 K |
| PP&E | 0.8 | 0.2 | 0.3 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | (0.2) | (0.3) | 0.2 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | (0.2) | 0 | 0 |
| Total Assets | 14.2 | 2.8 | 18.7 | 0.2 | 19 K | 29 K |
| LIABILITIES | ||||||
| Accounts Payable | 0.8 | 0.8 | 0.7 | 0.2 | 0.3 | 60 K |
| Short Term Debt | 0.3 | 0.3 | 0.3 | 2.5 | 0.5 | 1.0 |
| Other Current Liabilities | 16.4 | 2.1 | 1.1 | 0.2 | 0.1 | 0.1 |
| Total Current Liabilities | 17.5 | 3.3 | 2.1 | 2.9 | 0.9 | 1.2 |
| Long Term Debt | 0.5 | 0 | 0.2 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 18.0 | 3.3 | 2.3 | 2.9 | 0.9 | 1.2 |
| EQUITY | ||||||
| Common Stock | 35 K | 15 K | 15 K | 9 K | 8 K | 34 K |
| Retained Earnings | (64.5) | (34.0) | (15.9) | (5.9) | (3.7) | (1.5) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (3.8) | (0.5) | 16.5 | (2.7) | (0.9) | (1.2) |
| Total Liabilities and Equity | 14.2 | 2.8 | 18.7 | 0.2 | 19 K | 29 K |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 24.5 | 15.1 | 15.0 | 15.2 | 15.2 | 15.2 |